Results 71 to 80 of about 10,874,130 (155)

Organoids: From Bench to Bedside Applications

MedComm, Volume 7, Issue 6, June 2026.
Organoids, as a groundbreaking biomedical research platform, utilize adult stem cells (ASCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs) as sources. By integrating specific growth and differentiation signals within an extracellular matrix (e.g., Matrigel), organoids guide cells to self‐assemble into three‐dimensional ...
Kelin Li, Rui Cao, Maochen Li, Zichao Tian, Huahao Fan, Bixia Hong, Xiaojuan Liu   +6 more
wiley   +1 more source

Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system

, 2013
In analogy with histo-blood group A antigen, Forssman (Fs) antigen terminates with alpha 3-N-acetylgalactosamine and can be used by pathogens as a host receptor in many mammals.
Teneberg, Susann,, Jorgensen, Rene, Svensson, Lola, Svensson, Lola,, AK, Hult, Stamps, Robert, Henry, Stephen M., Martin L. Olsson, Rydberg, Lennart, Stephen M. Henry, ML, Olsson, SM, Henry, Hult, Annika,, Rydberg, Lennart,, Storry, Jill,, Storry, Jill, René Jørgensen, Jonas Ångström, Hult, Annika, Susann Teneberg, Olsson, Martin L, Jørgensen, R, Teneberg, Susann, Annika K. Hult, Lennart Rydberg, Robert Stamps, Angstrom, Jonas, R, Stamps, Ångström, Jonas,, Olsson, Martin L,, Jill R. Storry, Lola Svensson, Lund University., JR, Storry   +33 more
core   +1 more source

Histo-Blood Group Antigen-Producing Bacterial Cocktail Reduces Rotavirus A, B, and C Infection and Disease in Gnotobiotic Piglets

Viruses
The suboptimal performance of rotavirus (RV) vaccines in developing countries and in animals necessitates further research on the development of novel therapeutics and control strategies.
Sergei A. Raev, Maryssa K. Kick, Maria Chellis, Joshua O. Amimo, Linda J. Saif, Anastasia N. Vlasova   +5 more
doaj   +1 more source

Transfusion‐related alpha‐gal syndrome: Two new cases expanding the demographic and geographic spectrum, and evidence of a diagnostic gap in allergic transfusion reaction evaluation

Transfusion, Volume 66, Issue 6, Page 1167-1179, June 2026.
Abstract Background Transfusion‐related alpha‐gal syndrome (TRAGS) has recently been proposed as a cause of allergic transfusion reactions (ATRs) in which alpha‐gal‐specific IgE in sensitized group O (or potentially group A) recipients reacts with epitopes on group B or AB plasma‐containing components.
Mackenzie Foster, Miriam Brown, Angela Mueller, Toufik Tahiri, Kaycie Atchison, Deva Sharma, Cosby A. Stone Jr., Jonathan Tucci, Garrett S. Booth, Jeremy W. Jacobs   +9 more
wiley   +1 more source

Norovirus Gastroenteritis Outbreak with a Secretor-independent Susceptibility Pattern, Sweden

Emerging Infectious Diseases, 2010
Norovirus (NoV) is recognized as the commonest cause of acute gastroenteritis among adults. Susceptibility to disease has been associated with histo-blood group antigens and secretor status; nonsecretors are almost completely resistant to disease.
Johan Nordgren, Elin Kindberg, Per-Eric Lindgren, Andreas Matussek, Lennart Svensson   +4 more
doaj   +1 more source

Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection

mBio, 2020
Human noroviruses (HuNoVs) are the leading cause of nonbacterial gastroenteritis worldwide. Histo-blood group antigen (HBGA) expression is an important susceptibility factor for HuNoV infection based on controlled human infection models and epidemiologic
Kei Haga, Khalil Ettayebi, Victoria R. Tenge, Umesh C. Karandikar, Miranda A. Lewis, Shih-Ching Lin, Frederick H. Neill, B. Vijayalakshmi Ayyar, Xi-Lei Zeng, Göran Larson, Sasirekha Ramani, Robert L. Atmar, Mary K. Estes   +12 more
doaj   +1 more source

Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab‐soravtansine therapy

The Journal of Pathology: Clinical Research, Volume 12, Issue 3, May 2026.
Abstract Mirvetuximab‐soravtansine (MIRV‐S) is an antibody‐drug conjugate targeting folate receptor alpha (FOLR1). MIRV‐S is approved for the treatment of FOLR1‐positive, platinum‐resistant ovarian carcinoma. Patient eligibility is determined by immunohistochemistry (IHC) using a companion diagnostic (CDx) assay (FOLR1‐2.1, Ventana).
Annika Nasdala, Leonie D Kandt, Martin Radner, Nora Schaumann, Malte Gronewold, Pia Hillmann, Henriette Christgen, Jens Hachenberg, Elna Kuehnle, Christian Hartmann, Matthias Christgen   +10 more
wiley   +1 more source

Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants

, 2023
Rotavirus vaccine performance varies between high and low income countries. One possible explanation is inherited histo-blood group antigens (HBGAs) the expression of which differs between populations.
D M Whiley (13307013), C Cheung (9858590), Peter Sly (13095165), Claire Y. T. Wang (10581691), Robert Ware (12793483), A El-Heneidy (13307007), K Grimwood (10975860), S B Lambert (13307010)   +7 more
core  

Anti-Glycan Autoantibodies Induced by Helicobacter pylori as a Potential Risk Factor for Myocardial Infarction

Frontiers in Immunology, 2020
A number of epidemiological studies have evaluated the potential association between H. pylori and cardiovascular disease, but with contrasting results.
Riccardo Negrini, Vincenzo Villanacci, Claudio Poiesi, Antonella Savio   +3 more
doaj   +1 more source

A1vB Genotype With Weak A Antigen Expression: Resolution of an ABO Discrepancy Using Serological and Molecular Approaches

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 9, September 2026.
Wan‐Hua Yang, Fen‐Cing Liou
wiley   +1 more source